Partial Cystectomy for Primary Bladder Tumors in Contemporary Patients with Diverse Tumor Locations

2016 ◽  
Vol 3 (1) ◽  
pp. 55-61
Author(s):  
Matthew R. Danzig ◽  
Ari R. Berg ◽  
Rashed A. Ghandour ◽  
Danny Lascano ◽  
Michael J. Whalen ◽  
...  
Keyword(s):  
Partial Cystectomy ◽  
Bladder Tumors ◽  
Primary Bladder

scholarly journals Partial cystectomy: Is it a reliable option for the treatment of bladder

2013 ◽  
Vol 5 (1) ◽  
pp. 11 ◽  
Author(s):  
Yun-fei Xu ◽  
Guang-chun Wang ◽  
Jun-hua Zheng ◽  
Bo Peng
Keyword(s):  
Quality Of Life ◽  
Young Patients ◽  
Partial Cystectomy ◽  
Mesenchymal Tumour ◽  
Center Stage ◽  
Primary Bladder

Bladder leiomyosarcoma is a unique mesenchymal tumour,accounting for less than 0.5% of all primary bladder malignancies.Bladder leiomyosarcoma used to be treated with radical surgeryin either old or young patients, often resulting in significantimpact on the patients’s quality of life after surgery. We reporton a case of bladder leiomyosarcoma in a 31-year-old femalewho was treated with partial cystectomy. Fortunately, no tumourmetastasis or relapse was observed during the 7-year follow-upperiod and the patient now has a good quality of life. We foundthat partial cystectomy may be an acceptable option to treat bladderleiomyosarcoma in the low MSKCC (Memorial Sloan-KetteringCancer Center) stage.

Partial cystectomy with a bipolar sealing device in seven dogs with naturally occurring bladder tumors

2020 ◽  
Vol 49 (4) ◽  
pp. 794-799
Author(s):  
Milan Milovancev ◽  
Valery F. Scharf ◽  
Katy L. Townsend ◽  
Ameet Singh ◽  
Giovanni Tremolada ◽  
...  
Keyword(s):  
Partial Cystectomy ◽  
Bladder Tumors ◽  
Naturally Occurring ◽  
Sealing Device

scholarly journals Functional Bladder Paraganglioma Treated by Partial Cystectomy

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Amine Hermi ◽  
Hamza Ichaoui ◽  
Aziz Kacem ◽  
Houcem Hedhli ◽  
Faten Gargouri ◽  
...  
Keyword(s):  
Nervous System ◽  
Autonomic Nervous System ◽  
Urinary Bladder ◽  
Neuroendocrine Tumor ◽  
Transurethral Resection ◽  
Partial Cystectomy ◽  
Treatment Modalities ◽  
Rare Tumor ◽  
Bladder Tumors ◽  
Specific Symptoms

Paraganglioma is a rare neuroendocrine tumor that arises from the autonomic nervous system. The urinary bladder paraganglioma accounts for less than 0.1% of bladder tumors. It remains a challenging entity to diagnose and treat due to its rareness and the lack of specific symptoms. Treatment modalities include transurethral resection and cystectomy (partial or total). The authors report a new case of an isolated paraganglioma of the urinary bladder in a 52-year-old female patient that underwent partial cystectomy. This case aims to remind the clinical, histological and therapeutic features of this rare tumor.

Analysis of p21WAF1/CIP1 in Primary Bladder Tumors

1998 ◽  
Vol 159 (5) ◽  
pp. 1770-1770
Author(s):  
L. Lacombe ◽  
I. Orlow ◽  
D. Silver ◽  
W.L. Gerald ◽  
W.R. Fair ◽  
...  
Keyword(s):  
Bladder Tumors ◽  
Primary Bladder

Secondary Malignancies of the Bladder: Avoiding the Diagnostic Pitfall

2017 ◽  
Vol 26 (2) ◽  
pp. 120-125 ◽  
Author(s):  
Alexander Feldman ◽  
Samuel Borak ◽  
Soroush Rais-Bahrami ◽  
Jennifer Gordetsky
Keyword(s):  
Metastatic Tumor ◽  
Clinical History ◽  
Prior History ◽  
Bladder Tumors ◽  
Diagnostic Dilemma ◽  
Secondary Tumors ◽  
Diagnostic Pitfall ◽  
Imaging Characteristics ◽  
History Of ◽  
Primary Bladder

Although rare, secondary tumors of the bladder can present a diagnostic dilemma to pathologists considering a differential diagnosis of primary bladder cancer. We investigated the clinicopathologic and imaging characteristics of metastatic tumors to the bladder. We retrospectively reviewed the surgical pathology databases from 2 sites from 2013 to 2016, identifying 66 cases of secondary bladder tumors. Clinical, pathologic, and imaging findings were reviewed. Mean age at diagnosis was 63 years (range = 25-87). Females had a significantly higher proportion (44/66, 66.7%) of secondary bladder tumors compared with males (22/66, 33.3%; P = .007). In total, 56/66 (84.8%) patients had a clinical history of an in situ or invasive malignancy in another organ, and 54/66 (81.8%) patients had imaging supporting a metastatic tumor. Only 2/66 (3.0%) patients had a prior history of urothelial carcinoma. In total, 4/66 (6.1%) cases (all females) were originally misdiagnosed as primary bladder malignancies and were corrected after clinicoradiologic correlation. Overall, colorectal origin was most common (15/66, 22.7%), followed by cervical and ovarian primaries (10/66, 15.2% each). Cervical and ovarian origins predominated in the female cohort (10/44, 22.7% each), followed by endometrial (8/44, 18.2%). Colorectal and prostate primaries were the most common among males (10/22, 45.5%, and 7/22, 31.8%, respectively). Secondary bladder tumors can mimic urothelial carcinomas. In our cohort, gynecological, colorectal, and prostatic origins were most common. Clinical history, imaging, and immunohistochemical studies can be useful in avoiding this diagnostic pitfall.

Ten-Year Analysis of Primary Bladder Tumors at Brooke General Hospital

1964 ◽  
Vol 91 (5) ◽  
pp. 530-532 ◽  
Author(s):  
Robert J. Marsh ◽  
Frank E. Ceccarelli
Keyword(s):  
General Hospital ◽  
Bladder Tumors ◽  
Primary Bladder

Homozygous deletions but no sequence mutations in coding regions ofp15 orp16 in human primary bladder tumors

1995 ◽  
Vol 14 (3) ◽  
pp. 147-151 ◽  
Author(s):  
Joan P. Packenham ◽  
Jack A. Taylor ◽  
Colleen H. Anna ◽  
Catherine M. White ◽  
Theodora R. Devereux
Keyword(s):  
Bladder Tumors ◽  
Coding Regions ◽  
Primary Bladder ◽  
Homozygous Deletions

The natural history, treatment pattern, and survival of the patients with micropapillary bladder.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e15015-e15015
Author(s):  
Jue Wang
Keyword(s):  
Natural History ◽  
Tumor Stage ◽  
Invasive Disease ◽  
Population Based ◽  
Bladder Tumors ◽  
Cancer Specific Survival ◽  
Undifferentiated Histology ◽  
Primary Bladder ◽  
Muscle Invasive ◽  
Population Based Registry

e15015 Background: Micropapillary bladder carcinoma (MPBC) is a rare variant of urothelial carcinoma. The objective of this study was to examine the epidemiology, natural history, and prognostic factors of MPBC using population-based registry. Methods: The Surveillance, Epidemiology, and End Results (SEER) Program database was used to identify cases of MPBC by tumor site and histology codes. The clinical, demographic characteristics, treatment and survival of MPBC were examined. Results: A total of 98 cases of histology confirmed MPBC were identified between 2001 and 2007, this accounted for approximately 0.01% of all primary bladder tumors during the study period. Median age of the patients was 72 years (range 26-95). Of all the patients with MPBC, 56.1% had muscle invasive disease; 75.5% of patients had poorly or undifferentiated histology. A total of 30.6% of all patients (2.3% superficial disease; 52.7% of muscle-invasive MPBC) had radical or partial cystectomy. By logistic regression analysis, nonmuscle-invasive MPBC (OR 62.5, 95% CI 7.2-542.3) was associated with lower rate of utilization of cystectomy. The 1-, 3- and 5-year overall survival rate of MPBC were 84.5%, 57.3% and 42.3%. In multivariate analysis, tumor stage (HR 4.7, 95% CI 1.0-21.8) was found to be the only significant predictor for cancer-specific survival. Conclusions: The optimal therapy for MPBC remains undermined. Emphasis on early detection is needed to improve the outcome for patients with this malignancy.

Sign in / Sign up

Export Citation Format

Share Document